GGrantIndex
Sort

326,823 grants matching clinical trial

Selective Targeting of Pancreatic Cancer SPORE

$2,057,187
Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA

Hyperbaric Oxygen Brain Injury Treatment (HOBIT) Trial - CCC

$2,057,148
Gaylan L Rockswold · Hennepin Healthcare Research Institute · U01 · FY2018 · NS

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

$2,057,080
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA

The CAPTURE Study: Validating a unique COPD screening tool in primary care

$2,056,934
Fernando J Martinez · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · HL

SWITCH trial: Early feasibility study of Stentrode BCI for augmentative communication

$2,056,909
Douglas J Weber · Carnegie-Mellon University · UG3 · FY2021 · NS

MEDication Focused Outpatient Care for Underutilization of Secondary Prevention

$2,056,749
Barry L Carter · University Of Iowa · R18 · FY2016 · HL

COMPREHENSIVE SICKLE CELL CENTER

$2,056,484
Children'S Hospital Of Philadelphia · P60 · FY2001 · HL

ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah

$2,056,330
Torri D Metz · University Of Utah · U54 · FY2024 · HD

Case Western Reserve University/ Cleveland Clinic CTSA

$2,055,930
Pamela B Davis · Case Western Reserve University · KL2 · FY2007 · RR

BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects

$2,055,899
Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2016 · AG

TRIP-PCI: PAR1 Pepducin-Based Interventions in Arterial Thrombosis

$2,055,805
Athan Kuliopulos · Tufts Medical Center · P50 · FY2013 · HL

Androgen Receptor Action in Castration Resistant Prostate Cancer

$2,055,706
Steven P. Balk · Beth Israel Deaconess Medical Center · P01 · FY2015 · CA

CRP: Noninvasive brain stimulation for chronic pain treatment

$2,055,669
Laura Dipietro · Highland Instruments, Inc. · SB1 · FY2025 · AG

Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)

$2,055,632
Haian Fu · Emory University · P01 · FY2024 · CA

Anatomic Pathology Residency Program

$2,055,605
Frederic Barr · Division Of Basic Sciences - Nci · ZIE · FY2024 · CA

Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (RDCRC)

$2,055,558
David W Kimberlin · University Of Alabama At Birmingham · U54 · FY2019 · AI

Randomized Trial of Antenatal Late Preterm Steroids (ALPS) - DCC

$2,055,558
Elizabeth A Thom · George Washington University · U01 · FY2011 · HL

SPORE in GI Cancer

$2,055,518
Robert J Coffey · Vanderbilt University · P50 · FY2015 · CA

Harvard Clinical and Translational Science Center

$2,055,255
Lee Marshall Nadler · Harvard Medical School · KL2 · FY2017 · TR

Disease mechanism and therapies for retinal degeneration

$2,055,211
Tiansen Li · National Eye Institute · ZIA · FY2012 · EY

Methamphetamine Pharmacotherapy Development Center

$2,055,171
John E. Mendelson · California Pacific Med Ctr Res Institute · P50 · FY2006 · DA

Comprhensive Sickle Cell Center Program Project

$2,054,745
Marie J. Stuart · Thomas Jefferson University · U54 · FY2006 · HL

Brain Tumor Therapeutic Efficacy by Quantitative MR

$2,054,733
Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2017 · CA

CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer

$2,054,733
Marcela Valderrama Maus · Massachusetts General Hospital · UH3 · FY2025 · CA

The Exercise and Physical Activity Collaborative Team (ExPACT): A MoTrPAC Clinical Center

$2,054,615
Scott Trappe · Ball State University · U01 · FY2023 · AR